In present study, we aimed to detect the urinary CX3CL1 levels in patients with aMCI, patients with AD and normal cognitive function subjects, specifically explored the variability of urinary CX3CL1 levels among individuals of different ages. Here, CX3CL1 is linked to Alzheimer disease.